NFKB1 and diabetes mellitus: Although it has been previously shown that Ang-(1–7) can inhibit eNOS and IkB/NF-kB signaling pathways [33–38], the present study suggests that, at least in the case of diabetes-induced vascular dysfunction, this might arise from upstream inhibition of ErbB2 by Ang-(1–7).